Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
A Bolze, T Basler, S White, A Dei Rossi, D Wyman… - Med, 2022 - cell.com
Summary Background Between November 2021 and February 2022, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants co-circulated …
respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and Omicron variants co-circulated …
Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)
MG Mills, P Hajian, SM Bakhash, H Xie… - Journal of Clinical …, 2022 - Elsevier
Background Some mutations in the receptor binding domain of the SARS-CoV-2 Spike
protein are associated with increased transmission or substantial reductions in vaccine …
protein are associated with increased transmission or substantial reductions in vaccine …
SARS-CoV-2 co-infections and recombinations identified by long-read single-molecule real-time sequencing
P Trémeaux, J Latour, N Ranger, V Ferrer… - Microbiology …, 2023 - Am Soc Microbiol
Co-infection with at least 2 strains of virus is the prerequisite for recombination, one of the
means of genetic diversification. Little is known about the prevalence of these events in …
means of genetic diversification. Little is known about the prevalence of these events in …
SARS-CoV-2 genomic surveillance enables the identification of Delta/Omicron co-infections in Argentina
MB Pisano, P Sicilia, M Zeballos, A Lucca… - Frontiers in …, 2022 - frontiersin.org
Molecular surveillance of SARS-CoV-2 is crucial for the early detection of new variants and
lineages. In addition, detection of co-infections with more than one SARS-CoV-2 lineage has …
lineages. In addition, detection of co-infections with more than one SARS-CoV-2 lineage has …
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer …
Background There are limited data on clinical outcomes associated with the use of
bebtelovimab for the treatment of coronavirus disease 2019 (COVID‐19) among cancer …
bebtelovimab for the treatment of coronavirus disease 2019 (COVID‐19) among cancer …
SARS-CoV-2 origins: zoonotic Rhinolophus vs contemporary models
I Gulati, S Khan, G Gulati, SR Verma… - Biotechnology and …, 2022 - Taylor & Francis
The question of the origin of coronavirus spread like wildfire ever since it wreaked havoc
among humankind, and ever since the scientific community has worked tirelessly to trace the …
among humankind, and ever since the scientific community has worked tirelessly to trace the …
[HTML][HTML] SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case report
A Abroi, UG Talas, M Pauskar, A Shablinskaja… - International Journal of …, 2022 - Elsevier
Despite the high number of SARS-CoV-2 infections, only a few cases of dual infection have
been reported. Here, we describe a case of COVID-19 caused simultaneously by Delta and …
been reported. Here, we describe a case of COVID-19 caused simultaneously by Delta and …